SES · H02.SI
Haw Par Corporation Limited
SGD 12.96+SGD 0.08 (+0.62%)
Haw Par Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 29.06% below the high.
Loading market information…
SES · BSL.SI · SGD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:04 AM UTC. Cached market data; not a live quote.
One-year closing-price history · SGD. Historical prices are not a forecast.
Raffles Medical Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.07% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Raffles Medical Group Ltd’s forward annual dividend is SGD 0.03 per share, paid annual. The forward yield is 3.66% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Raffles Medical Group Ltd’s next earnings report is currently expected on Feb 22, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Raffles Medical Group Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Raffles Medical Group Ltd (RMG), a prominent Singapore-headquartered company, delivers integrated private healthcare services across Singapore, Greater China, Vietnam, Cambodia, and Japan. Its operations are structured into Healthcare Services, Hospital Services, and Investment Holdings segments. The group's flagship institution, Raffles Hospital, functions as a tertiary care facility, offering a broad spectrum of medical services. These include oncology, pediatrics and women's health, traditional Chinese medicine, counseling, dental care, dialysis, diabetes and endocrinology, ENT, ophthalmology, fertility treatments, cardiology, internal medicine, neuroscience, pain management, rehabilitation, orthopedics, dermatological and aesthetic services, general surgery, nuclear medicine, and urology. Beyond the hospital, RMG provides emergency services, family medicine, comprehensive health screening, and a variety of multi-disciplinary specialist clinic services. Additionally, the company engages in the trade of pharmaceutical and nutraceutical products, and diagnostic equipment. It also offers advisory and consultancy services, develops IT solutions, and undertakes research and experimental development in biotechnology, life sciences, and medical science. The company was founded in 1976.
Latest available per-share figures in SGD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:01 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| SGD 0.01 |
| SGD 182.85M |
| Q4 2023 | Feb 26, 2024 | SGD 0.02 | SGD 336.17M-53.07% vs estimate |
|---|
| Q2 2023 | Jul 31, 2023 | SGD 0.03 | SGD 370.85M |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
SGD 12.96+SGD 0.08 (+0.62%)
Haw Par Corporation Limited’s quoted price sits in the lower half of its reported 52-week range, 29.06% below the high.
SGD 0.05+SGD 0.00 (+2.13%)
Thomson Medical Group Limited’s quoted price sits in the lower half of its reported 52-week range, 28.36% below the high.
SGD 0.74-SGD 0.01 (-0.68%)
Riverstone Holdings Limited’s quoted price sits in the lower half of its reported 52-week range, 25.38% below the high.
$9.58-$0.70 (-6.81%)
Adlai Nortye Ltd.’s quoted price sits in the upper half of its reported 52-week range, 44.29% below the high.
$0.46-$0.02 (-3.16%)
UltraGreen.ai Limited’s quoted price sits in the lower half of its reported 52-week range, 75.27% below the high.
SGD 0.51+SGD 0.01 (+2.0%)
iX Biopharma Ltd.’s quoted price sits in the upper half of its reported 52-week range, 18.4% below the high.
SGD 0.49SGD 0.00 (0.0%)
Q & M Dental Group (Singapore) Limited’s quoted price sits in the lower half of its reported 52-week range, 22.83% below the high.
SGD 0.34SGD 0.00 (0.0%)
HC Surgical Specialists Limited’s quoted price sits in the lower half of its reported 52-week range, 15.0% below the high.
